Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Hovione today announced the signing of a partnership agreement with Ligand to significantly ramp up the production output of Captisol®
Scientist Live, 12 May 2025
BCSD Portugal, 23 July 2021
The agreement furthers Hovione´s ability to bring the benefits of continuous tableting, including reduced time to market and increased supply chain flexibility, to pharmaceutical customers globally
Effective May 1st, 2020
Investment in Hovione Tejo will expand industrial capacity and strengthen the company’s global leadership in spray drying and other advanced pharmaceutical manufacturing technologies.
Showing promise in Dry Eye Disease associated with Inflamed Meibomian Gland Dysfunction
Google Chrome
Safari
Firefox
Edge